phloretin has been researched along with Angiogenesis, Pathologic in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Phloretin (100 μM) treatment significantly inhibited the aldehyde dehydrogenase 1 activity of SiHa cells, reduced the self-renewal properties and stemness signatures of CD44 and Sox-2 in sphere-forming cervical cancer-derived tumor-initiating cells, and inhibited the invasion, MMP-2 activity, and tube formation capacity of human umbilical vein endothelial cells." | 1.51 | Phloretin suppresses metastasis by targeting protease and inhibits cancer stemness and angiogenesis in human cervical cancer cells. ( Chen, PN; Chen, SP; Hsiao, YH; Hsieh, MJ; Tsai, WC; Yang, SF, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsiao, YH | 1 |
| Hsieh, MJ | 1 |
| Yang, SF | 1 |
| Chen, SP | 1 |
| Tsai, WC | 1 |
| Chen, PN | 1 |
1 other study available for phloretin and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Phloretin suppresses metastasis by targeting protease and inhibits cancer stemness and angiogenesis in human cervical cancer cells.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Female; Gene Ex | 2019 |